IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · IEX Real-Time Price · USD
477.23
+0.83 (0.17%)
At close: Jul 2, 2024, 4:00 PM
477.02
-0.21 (-0.04%)
After-hours: Jul 2, 2024, 6:57 PM EDT
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for IDEXX Laboratories stock have an average target of 583, with a low estimate of 510 and a high estimate of 650. The average target predicts an increase of 22.16% from the current stock price of 477.23.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IDXX stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $520 → $510 | Hold | Maintains | $520 → $510 | +6.87% | Jun 24, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $620 → $596 | Buy | Maintains | $620 → $596 | +24.89% | May 14, 2024 |
| Barclays | Barclays | Buy Maintains $655 → $570 | Buy | Maintains | $655 → $570 | +19.44% | May 2, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $600 → $630 | Buy | Maintains | $600 → $630 | +32.01% | Feb 6, 2024 |
| Barclays | Barclays | Buy Maintains $605 → $655 | Buy | Maintains | $605 → $655 | +37.25% | Feb 6, 2024 |
Financial Forecast
Revenue This Year
4.02B
from 3.66B
Increased by 9.78%
Revenue Next Year
4.42B
from 4.02B
Increased by 9.95%
EPS This Year
11.27
from 10.06
Increased by 12.00%
EPS Next Year
12.83
from 11.27
Increased by 13.91%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.2B | 4.6B | 5.2B | 5.6B | 6.1B |
| Avg | 4.0B | 4.4B | 4.9B | 5.3B | 5.8B |
| Low | 3.8B | 4.2B | 4.5B | 5.0B | 5.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.4% | 15.3% | 16.9% | 14.5% | 14.7% |
| Avg | 9.8% | 10.0% | 10.1% | 9.0% | 8.8% |
| Low | 5.0% | 3.3% | 1.5% | 2.3% | 2.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.66 | 13.83 | 15.86 | 18.20 | 19.94 |
| Avg | 11.27 | 12.83 | 14.74 | 16.49 | 17.80 |
| Low | 10.73 | 11.88 | 13.33 | 14.04 | 15.59 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.9% | 22.7% | 23.5% | 23.5% | 20.9% |
| Avg | 12.0% | 13.9% | 14.8% | 11.9% | 7.9% |
| Low | 6.7% | 5.4% | 3.8% | -4.7% | -5.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.